Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
about
Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegansIdentification of human proteins that modify misfolding and proteotoxicity of pathogenic ataxin-1Huntingtin interacting proteins are genetic modifiers of neurodegenerationPersistence of morning anticipation behavior and high amplitude morning startle response following functional loss of small ventral lateral neurons in DrosophilaThe importance of integrating basic and clinical research toward the development of new therapies for Huntington diseaseIdentification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domainAtaxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomesAlpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicityThe selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein AlfyAtaxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptorsLife extension in Drosophila by feeding a drug.Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis.A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formationCdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's diseaseHuntingtin in health and diseaseMultiple Aspects of Gene Dysregulation in Huntington's DiseaseImproved activities of CREB binding protein, heterogeneous nuclear ribonucleoproteins and proteasome following downregulation of noncoding hsromega transcripts help suppress poly(Q) pathogenesis in fly modelsNicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotauNitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosisThe HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.Connecting the dots in Huntington's disease with protein interaction networksTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesNucleolar dysfunction in Huntington's diseaseThe emerging role of acetylation in the regulation of autophagyHuntington's disease: the past, present, and future search for disease modifiers.Transgenic animal models for study of the pathogenesis of Huntington's disease and therapyThe interplay between microRNAs and histone deacetylases in neurological diseasesHuntington's disease: underlying molecular mechanisms and emerging conceptsTranscriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasisComparative study of naturally occurring huntingtin fragments in Drosophila points to exon 1 as the most pathogenic species in Huntington's diseaseImpaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtinSAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's diseaseNebula/DSCR1 upregulation delays neurodegeneration and protects against APP-induced axonal transport defects by restoring calcineurin and GSK-3β signalingPulsed Light Stimulation Increases Boundary Preference and Periodicity of Episodic Motor Activity in Drosophila melanogasterHigh-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease modelHuntingtin's function in axonal transport is conserved in Drosophila melanogasterA genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease.Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regenerationThe promise and perils of HDAC inhibitors in neurodegenerationDrosophila as an In Vivo Model for Human Neurodegenerative Disease
P2860
Q21144448-6BFE294C-C2E7-4A95-A8A8-C7CB9B9771EDQ21144909-791395A6-7D00-4802-ABD1-3CCE6A6860D9Q21145230-09ACDC68-9D90-4C99-BD45-7D6C9F051F50Q21562193-FD2073B0-1C27-4E95-A232-5ED24AC4DB2BQ22306292-A2B31378-AC01-4B51-BC8B-51864C19AC8FQ24292353-2E768EC0-D062-4ADC-B401-72DF2915E53FQ24296835-FAD575CE-9B05-403F-A0CE-E415659973D7Q24301946-D475659F-7DFC-4898-8717-7602167B591CQ24307759-767284F9-7205-4C7A-8664-78187CFE6B25Q24316293-B5F65889-F04E-44FB-9B9E-AA8144231E01Q24530572-0D50C304-289F-4BCE-9EC9-558A970AE406Q24534867-C684E63C-02B4-4857-97D0-726C5DA2D192Q24543178-3EDD50A7-A896-4C3C-A4ED-D81FB26070D2Q24554218-E7E4812D-9856-42C5-AFBE-5FA7464024DFQ24554374-20ACD5CE-C686-4D3B-BDA7-F7DC5D7DEC75Q24605880-F0CB51B5-200E-4428-AAA8-D9F1D428E33FQ24626685-A231E9A0-F68F-469B-99E4-FADF7D5AFD0AQ24651880-0508503F-F906-4EBE-97B7-949B1F3A3A9AQ24652801-2FBED11A-B051-40D6-8F85-E3DCD3E15E43Q24656405-D9D57C7C-7F59-4BBA-8F72-6351C6F21715Q24797069-5E45EF14-0339-41A6-836F-D13C45752CA2Q26771812-48578C1F-5E8E-4500-BD80-80E83D5206EEQ26822451-1C33AB3D-1295-45A6-BC73-B97900DD86A1Q26829365-C85C509F-5CDF-463C-8D11-D964B603A1AEQ26830039-F7C73371-D4AF-44BD-BF55-AD8A5E515793Q26849677-B8C3D83C-C820-4F1F-ABBE-695040EE295FQ27024466-88C1B8FB-FA55-4EDF-A8B4-60477260498AQ27026255-804F40A2-3B0E-40B4-BFA3-F335330F1DA2Q27026549-259C7DB6-6231-4D3A-89E2-7F2BD6A79AC1Q27301252-F1E81CC4-B2DB-475E-829C-9AFB25517D9CQ27312215-47277C2D-D3ED-4218-AF3E-BF38F0E145C2Q27312323-ECB2EC00-90BC-4C5C-9C01-4DBAE339F142Q27320509-7B4C87CB-2FC4-4BD4-B3DD-59B5A2091FB0Q27320892-0956BADC-7299-417F-8E5A-16666899E28EQ27323092-C97885B0-0212-498B-A22A-2A75457A8761Q27331461-5D7A3039-2876-4873-AC0D-D3FF4AF47D5FQ27933811-4C281BA2-F912-48D2-87B7-E42CB754F7BCQ28080593-F0799D8F-50E8-4B9C-A708-6FFC77AA87C9Q28087539-E50E1C0B-D8E7-4FE2-92DB-D634544FFCA7Q28088777-647DEF3A-52A6-4C8D-8D35-EB1A9EC389AA
P2860
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Histone deacetylase inhibitors ...... eurodegeneration in Drosophila
@ast
Histone deacetylase inhibitors ...... eurodegeneration in Drosophila
@en
type
label
Histone deacetylase inhibitors ...... eurodegeneration in Drosophila
@ast
Histone deacetylase inhibitors ...... eurodegeneration in Drosophila
@en
prefLabel
Histone deacetylase inhibitors ...... eurodegeneration in Drosophila
@ast
Histone deacetylase inhibitors ...... eurodegeneration in Drosophila
@en
P2093
P3181
P356
P1433
P1476
Histone deacetylase inhibitors ...... eurodegeneration in Drosophila
@en
P2093
A Kazantsev
A McCampbell
B L Apostol
D E Housman
G R Jackson
J S Steffan
L M Thompson
P2888
P304
P3181
P356
10.1038/35099568
P407
P50
P577
2001-10-01T00:00:00Z
P5875
P6179
1025528785